amifostine anhydrous has been researched along with curcumin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JY; Chen, SY; Chiang, CS; Chiang, MY; Huang, WC; Li, WM; Su, CW | 1 |
| Mercantepe, F; Mercantepe, T; Topcu, A; Tumkaya, L; Yılmaz, A | 1 |
2 other study(ies) available for amifostine anhydrous and curcumin
| Article | Year |
|---|---|
Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer.
Topics: Amifostine; Animals; Calcium Phosphates; Curcumin; Delayed-Action Preparations; Doxorubicin; Female; Gelatin; Humans; Hydrogen-Ion Concentration; Magnetics; MCF-7 Cells; Mice; Nanoparticles; Receptor, ErbB-2 | 2015 |
Protective effects of amifostine, curcumin, and melatonin against cisplatin-induced acute kidney injury.
Topics: Acute Kidney Injury; Amifostine; Animals; Antineoplastic Agents; Antioxidants; Cisplatin; Curcumin; Male; Melatonin; Rats, Sprague-Dawley | 2018 |